I do have to question the blind faith. Frankly I find it remarkable.
Given that Stephen, Peter Anastasiou and Roger Aston have all departed reasonably recently how possibly could IMC be on the precipice of greatness?
Three long term extremely high volume holders dump and run on the eve (relative to their years of involvement) of IMC’s greatness.
I am very happy for someone to explain it to me as if I were a child.
What am I missing?
Ann: Travelan to progress to Phase 3 Clinical Trials in the US, page-187
-
- There are more pages in this discussion • 28 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
